Possible Role of Prostanoids as Mediators in the Pathogenesis of Inflammatory Bowel Disease

  • Daniel Rachmilewitz
  • A. J. Treves
  • M. Ligumsky
  • P. Sharon
  • A. Zifroni
  • F. Karmeli
Part of the Developments in Gastroenterology book series (DIGA, volume 3)

Abstract

The etiology of ulcerative colitis and Crohn’s disease is still not known. Various themes were suggested: allergic, dietary, infectious, autoimmune, vascular, psychosomatic and others, but none has so far yielded any conclusive answers. Irrespective of the specific etiology, the possibility that prostanoids may have a role as mediators in the inflammatory process and in the alteration in intestinal secretory and absorptive function in IBD was explored in the present study.

Keywords

Aspirin Sedimentation Adenosine Diarrhea Pyruvate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moncada S, Vane JR. 1979. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol Rev, 30: 293–331.Google Scholar
  2. 2.
    Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 231: 232–235.Google Scholar
  3. 3.
    Floman Y, Zor U. 1976. Mechanism of steroid action in inflammation: inhibition of prostaglandin synthesis and release. Prostaglandins, 12: 403–413.PubMedCrossRefGoogle Scholar
  4. 4.
    Rachmilewitz D. 1980. Prostaglandins and diarrhea. Dig Dis Sci, 35: 897–899.CrossRefGoogle Scholar
  5. 5.
    Ventrappen G, Popiela T, Tytgat DNJ, et al. 1980. A multicenter trial of 15(R)-15 methyl prostaglandin E2 in duodenal ulcer. Gastroenterology 78: 1283.Google Scholar
  6. 6.
    Sharon P, Ligumsky M, Rachmilewitz D, et al. 1978. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology 75: 638–640.PubMedGoogle Scholar
  7. 7.
    Treves AJ, Yagoda D, Haimovitz A, et al. 1980. The isolation and purification of human peripheral blood monocytes in cell suspension. J Immunol Methods 39: 71–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Bull DM, Bookman MA. 1977. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 59: 966–974.PubMedCrossRefGoogle Scholar
  9. 9.
    Bauminger S, Zor U, Lindner HR. 1973. Radioimmunological assay of prostaglandin synthetase activity. Prostaglandins 4: 313–324.PubMedCrossRefGoogle Scholar
  10. 10.
    Ligumsky M, Karmeli F, Sharon P, et al. 1981. Enhanced thromboxan A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterolog 81: 444–449.Google Scholar
  11. 11.
    Tripp JH, Manning JA, Muller DRP, et al. 1978. Mucosal adenylate cyclase and sodium-potassium stimulated adenosine triphosphate in jejunal biopsies of adults and children with coeliac disease. Eds. McNichol B, McCarthy CF, Fottrell PF, MTP Press, Lancaster, UK, 461–470.Google Scholar
  12. 12.
    Salomon Y, Londos C, Rodbell H. 1974. A highly sensitive cyclase assay. Anal Biochem. 58: 541–548.PubMedCrossRefGoogle Scholar
  13. 13.
    Lowry OH, Rosebrough NH, Farr AL, et al. 1951. Protein measurement with phenol reagent. J Biol Chem 193: 265–275.PubMedGoogle Scholar
  14. 14.
    Hawkey CJ, Truelove SC. 1981. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut 22: 190–193.PubMedCrossRefGoogle Scholar
  15. 15.
    Sinzinger H, Silberbaver K, Seyfriend H. 1979. Rectal mucosal prostacyclin formation in active ulcerative colitis. Lancet is 444.Google Scholar
  16. 16.
    Smith PR, Dawson DJ, Swan CHJ. 1979. Prostaglandin synthetase activity in acute ulcerative colitis: effects of treatment with sulphasalazine codeine phosphate and prednisolone. Gut 20: 802–805.PubMedCrossRefGoogle Scholar
  17. 17.
    Ford-Hutchinson AW, Bray MA, Doig MV, et al. 1980. Leukotriene B a potent chemokinetic and aggregating substance released from polymor phonuclear leukocytes. Nature 286: 264–265.PubMedCrossRefGoogle Scholar
  18. 18.
    Thayer WR, Charland C, Field CA. 1976. The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology 71: 379–384.PubMedGoogle Scholar
  19. 19.
    Hoult JRS, Moore PK. 1980. Effects of sulphasalazine and its metabolites on prostaglandin synthesis inactivation and actions on smooth muscle. Br J Pharmacol 68: 719–740.PubMedGoogle Scholar
  20. 20.
    Campieri M, Lanfranchi GA, Bazzocchi G, et al. 1978. Salicylate other than 5-amino salicylate acid ineffective in ulcerative colitis (lett). Lancet II: 993.CrossRefGoogle Scholar
  21. 21.
    Klotz U, Maier K, Fischer C, et al. 1980. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn’s disease. N E J M 303: 1499–1502.CrossRefGoogle Scholar
  22. 22.
    Charney AM, Donowitz M. 1978. Functional significance of intestinal Na+-K+-ATPase: in vivo ouabain inhibition. Am J Physiol 234: 629–636.Google Scholar
  23. 23.
    Kimberg DV. 1974. Cyclic nucleotides and their role in gastrointestinal secretion. Gastroenterology 67: 1023–1064.Google Scholar
  24. 24.
    Mozsik G, Kutas J, Nemeth G. 1974. Inhibition of Mgt+-Na+-K+dependent ATPase system from human gastric mucosa by prostaglandins E1 and E2. Europ J Pharmacol 29: 133–137.CrossRefGoogle Scholar
  25. 25.
    Sharon P, Karmeli F, Rachmilewitz D. 1981. Celiac disease, pernicious anemia, colchicine therapy and ulcerative colitis: A common role for Na-K-ATPase in decreased intestinal water absorption. Gastroenterology 80: 1282.Google Scholar

Copyright information

© Martinus Nijhoff Publishers, The Hague 1982

Authors and Affiliations

  • Daniel Rachmilewitz
  • A. J. Treves
  • M. Ligumsky
  • P. Sharon
  • A. Zifroni
  • F. Karmeli

There are no affiliations available

Personalised recommendations